This guide was reviewed by a Business News Daily editor to ensure it provides comprehensive and accurate information to aid your buying decision. As technologies that capture and analyze data ...

NEW YORK – Data center developers have shown interest in building AI hubs in a more sustainable way, speakers said at Axios House at Climate Week and the UN General Assembly. Why it matters: The AI ...

Scuderia Ferrari Formula One driver Charles Leclerc's name has appeared in a brainwave data breach following an investigation. It is alleged that China might have stolen brainwave data through a focus ...

The government on Sunday termed as "misleading" reports in a section of the media that "notices" have been sent to Hindi news channels for excessive use of Urdu words in their broadcasts. Kindly note ...

BOSTON and LONDON, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today ...

Newly discovered npm package 'fezbox' employs QR codes to retrieve cookie-stealing malware from the threat actor's server. The package, masquerading as a utility library, leverages this innovative ...

Data highlights ability of Akari’s ADC payload, PH1, to suppress the levels of the AR-V7 receptor that is responsible for driving hormone refractory prostate cancer progression BOSTON and LONDON, Sept ...

Radware has created a zero-click indirect prompt injection technique that could bypass ChatGPT to trick OpenAI servers into leaking corporate data. For years threat actors have used social engineering ...

A judge in New York rejected a request on 23 September to disqualify the use of cutting-edge DNA sequencing as evidence in a case against an alleged serial killer. The ruling paves the way for a type ...

Akari Therapeutics plc has released preclinical data demonstrating the potential of its novel antibody-drug conjugate (ADC) spliceosome modulating payload, PH1, for the treatment of tumors driven by ...

Akari Therapeutics (AKTX) has filed a provisional patent application with the United States Patent and Trademark Office covering the Company’s antibody drug conjugate platform using Akari’s ...